Exact Mass: 419.1544566
Exact Mass Matches: 419.1544566
Found 85 metabolites which its exact mass value is equals to given mass value 419.1544566
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(14E)-2,11-dihydroxy-14-(1H-imidazol-5-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione
C22H21N5O4 (419.15934660000005)
SCD1 Inhibitor
Glycine, L-gamma-glutamyl-2-(1-methyl-4-(nitrosothio)-4-piperidinyl)glycyl-
5-[[1-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]imidazol-2-yl]amino]-3-methylimidazole-2,4-dione
C22H21N5O4 (419.15934660000005)
Glandicoline B
C22H21N5O4 (419.15934660000005)
An indole alkaloid with a tetracyclic skeleton that is isolated from Penicillium chrysogenum. CONFIDENCE Penicillium bissettii
5-(alpha-Glucosidomethyl)deoxycytidin|O5-D-glucopyranosyloxymethyl-2-deoxy-cytidine
C16H25N3O10 (419.15398700000003)
Cys Asn Pro Ser
Cys Asn Ser Pro
Cys Pro Asn Ser
Cys Pro Ser Asn
Cys Ser Asn Pro
Cys Ser Pro Asn
Asn Cys Pro Ser
Asn Cys Ser Pro
Asn Pro Cys Ser
Asn Pro Ser Cys
Asn Ser Cys Pro
Asn Ser Pro Cys
Pro Cys Asn Ser
Pro Cys Ser Asn
Pro Asn Cys Ser
Pro Asn Ser Cys
Pro Ser Cys Asn
Pro Ser Asn Cys
Ser Cys Asn Pro
Ser Cys Pro Asn
Ser Asn Cys Pro
Ser Asn Pro Cys
Ser Pro Cys Asn
Ser Pro Asn Cys
(3R,4S)-3-Azetidinepropanoic acid,1-(4-fluorophenyl)-2-oxo-4[4(phenylmethoxy)phenyl]-methyl ester
C25H22FNO4 (419.15327840000003)
Fmoc-(S)-3-Amino-4-(2-fluoro-phenyl)-butyric acid
C25H22FNO4 (419.15327840000003)
(S)-N-FMOC-alpha-Methyl-2-fluorophenylalanine
C25H22FNO4 (419.15327840000003)
Fmoc-(S)-3-Amino-4-(4-fluorophenyl)-butyric acid
C25H22FNO4 (419.15327840000003)
Fmoc-(R)-3-Amino-4-(2-fluorophenyl)-butyric acid
C25H22FNO4 (419.15327840000003)
Fmoc-(S)-3-Amino-4-(3-fluorophenyl)-butyric acid
C25H22FNO4 (419.15327840000003)
N-(2-(3-(PIPERAZIN-1-YLMETHYL)IMIDAZO[2,1-B]THIAZOL-6-YL)PHENYL)PYRAZINE-2-CARBOXAMIDE
C21H21N7OS (419.15282160000004)
SCD1 inhibitor
fmoc-(r)-3-amino-4-(3-fluoro-phenyl)-butyric acid
C25H22FNO4 (419.15327840000003)
CHIR-124
C23H22ClN5O (419.15127920000003)
(1S,2R,5S)-5-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-A]pyrazin-7(8H)-YL]-2-(2,4,5-trifluorophenyl)cyclohexanamine
7-[(2-Chloro-6-fluorophenyl)methyl]-1,3-dimethyl-8-(1-piperidinylmethyl)purine-2,6-dione
2-ethyl 4-isopropyl 5-{[3-(1,5-dimethyl-1H-pyrazol-4-yl)acryloyl]amino}-3-methyl-2,4-thiophenedicarboxylate
C20H25N3O5S (419.15148400000004)
3-(Methoxymethyl)-2-benzofurancarboxylic acid [4-amino-6-(2-methylanilino)-1,3,5-triazin-2-yl]methyl ester
C22H21N5O4 (419.15934660000005)
4-[[(4-acetamidophenyl)sulfonylamino]methyl]-N-(3-methoxypropyl)benzamide
C20H25N3O5S (419.15148400000004)
N-[2-[(1,3-benzodioxol-5-ylmethylamino)-oxomethyl]phenyl]-2-ethoxy-3-pyridinecarboxamide
C23H21N3O5 (419.14811360000004)
2-(1H-benzimidazol-2-yl)-N-(4-phenylmethoxyphenyl)benzamide
N-[(2S,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
C20H25N3O5S (419.15148400000004)
N-[(2S,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
C20H25N3O5S (419.15148400000004)
N-[(2S,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
C20H25N3O5S (419.15148400000004)
N-[(2R,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
C20H25N3O5S (419.15148400000004)
N-[(2R,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
C20H25N3O5S (419.15148400000004)
N-[(2R,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
C20H25N3O5S (419.15148400000004)
N-[(2S,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
C20H25N3O5S (419.15148400000004)
N-[(2R,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
C20H25N3O5S (419.15148400000004)
N(6)-acetyl-N(2)-(5-phosphopyridoxyl)-L-lysine
A N(6)-acyl-L-lysine arising from reductive N-alkylation of N(6)-acetyl-L-lysine by pyridoxal-5-phosphate.
ascofuranone(1-)
C23H28ClO5 (419.16251680000005)
A phenolate anion that is the conjugate base of ascofuranone resulting from the deprotonation of the 4-hydroxy group. Major species at pH 7.3.
hnRNPK-IN-1
C23H21N3O5 (419.14811360000004)
hnRNPK-IN-1 is a heterogeneous nuclear ribonucleoprotein K (hnRNPK) binding ligand with Kd values of 4.6 μM and 2.6 μM measured with SPR and MST, respectively. hnRNPK-IN-1 inhibits c-myc transcription by disrupting the binding of hnRNPK and c-myc promoter. hnRNPK-IN-1 induces Hela cells apoptosis and has strongly anti-tumor activities[1].
15'-(aminomethyl)-16'-chloro-5-hydroxy-2,3'-diimino-2',4',6',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-7',9'-dien-11'-one
(1'r,4r,5r,5's,14'r,15's,16'r,18's)-15'-(aminomethyl)-16'-chloro-5-hydroxy-2,3'-diimino-2',4',6',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-7',9'-dien-11'-one
3-{[4-(hex-4-enoyl)-5,7-dihydroxy-3,6,7a-trimethyl-2-oxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid
(1's,4s,5r,5'r,14's,15'r,16's,18'r)-15'-(aminomethyl)-16'-chloro-5-hydroxy-2,3'-diimino-2',4',9',12'-tetraazaspiro[imidazolidine-4,17'-pentacyclo[10.6.0.0¹,⁵.0⁶,¹⁰.0¹⁴,¹⁸]octadecane]-6'(10'),7'-dien-11'-one
3-{[7-hydroxy-4-(1-hydroxyhex-4-en-1-ylidene)-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid
2-hydroxy-5-({1-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]imidazol-2-yl}imino)-3-methylimidazol-4-one
C22H21N5O4 (419.15934660000005)